 CAMBRIDGE, United Kingdom, March 24, 2021 GLOBE NEWSWIRE -- Today Abcam AIM:ABC; NASDAQ:ABCM, a global innovator in life science reagents and tools, announced that Dr Alejandra Solache, SVP of Research Development received the CiteAb award for Significant Individual Impact and the Company was recognized as Antibody Supplier Succeeding in Cardiovascular Research. 